Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
Kennedy GA, Varelias A, Vuckovic S, Le Texier L, Gartlan KH, Zhang P, Thomas G, Anderson L, Boyle G, Cloonan N, Leach J, Sturgeon E, Avery J, Olver SD, Lor M, Misra AK, Hutchins C, Morton AJ, Durrant ST, Subramoniapillai E, Butler JP, Curley CI, MacDonald KPA, Tey SK, Hill GR. Kennedy GA, et al. Among authors: anderson l. Lancet Oncol. 2014 Dec;15(13):1451-1459. doi: 10.1016/S1470-2045(14)71017-4. Epub 2014 Nov 14. Lancet Oncol. 2014. PMID: 25456364 Clinical Trial.
The history of suture anchors in orthopaedic surgery.
Visscher LE, Jeffery C, Gilmour T, Anderson L, Couzens G. Visscher LE, et al. Among authors: anderson l. Clin Biomech (Bristol, Avon). 2019 Jan;61:70-78. doi: 10.1016/j.clinbiomech.2018.11.008. Epub 2018 Nov 23. Clin Biomech (Bristol, Avon). 2019. PMID: 30502638 Review.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Callander NS, Silbermann R, Kaufman JL, Godby KN, Laubach J, Schmidt TM, Sborov DW, Medvedova E, Reeves B, Dhakal B, Rodriguez C, Chhabra S, Chari A, Bal S, Anderson LD Jr, Dholaria BR, Nathwani N, Hari P, Shah N, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Pei H, Cortoos A, Patel S, Lin TS, Giri S, Costa LJ, Usmani SZ, Richardson PG, Voorhees PM. Callander NS, et al. Among authors: anderson ld jr. Blood Cancer J. 2024 Apr 22;14(1):69. doi: 10.1038/s41408-024-01030-w. Blood Cancer J. 2024. PMID: 38649340
Similar Efficacy and Lower Cost Associated with Ceftazidime Compared to Tobramycin Coupled with Vancomycin in Antibiotic Spacers in the Treatment of Periprosthetic Joint Infection.
Lewis D, Blackburn BE, Archibeck J, Archibeck MJ, Anderson LA, Gililland JM, Certain LK, Pelt C. Lewis D, et al. Among authors: anderson la. J Arthroplasty. 2024 Apr 15:S0883-5403(24)00330-9. doi: 10.1016/j.arth.2024.04.018. Online ahead of print. J Arthroplasty. 2024. PMID: 38631513
Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program.
Nwachukwu C, Makhnoon S, Person M, Muthukrishnan M, Kazmi S, Anderson LD, Kaur G, Kapinos KA, Williams EL, Fatunde O, Sadeghi N, Robles F, Basey A, Hulsey T, Pruitt SL, Gerber DE. Nwachukwu C, et al. Among authors: anderson ld. Contemp Clin Trials Commun. 2024 Apr 8;39:101292. doi: 10.1016/j.conctc.2024.101292. eCollection 2024 Jun. Contemp Clin Trials Commun. 2024. PMID: 38623454 Free PMC article.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Silbermann R, Laubach J, Kaufman JL, Sborov DW, Reeves B, Rodriguez C, Chari A, Costa LJ, Anderson LD Jr, Nathwani N, Shah N, Bumma N, Holstein SA, Costello C, Jakubowiak A, Orlowski RZ, Shain KH, Cowan AJ, Gries KS, Pei H, Cortoos A, Patel S, Lin TS, Voorhees PM, Usmani SZ, Richardson PG. Silbermann R, et al. Among authors: anderson ld jr. Am J Hematol. 2024 Apr 15. doi: 10.1002/ajh.27326. Online ahead of print. Am J Hematol. 2024. PMID: 38622840
4,750 results